The BIA’s Board is drawn from a wide range of member companies. The Board currently comprises 15 Members, each of whom has been elected for a three-year term, after which they are invited to put themselves forward for re-election.

Board Members

Dr Jane Osbourn

MedImmune

 

Eva-Lotta Allan

Immunocore

Dr Charles Brigden

BTG

Dr Kevin Cox

Imanova

Dr Darrin Disley

Horizon Discovery Group

David Hipkiss

Dr Andrew Lightfoot

Oaktree Bioscience

Dr Neil Murray

Redx Pharma

Brenda Reynolds

Calchan

Keith Thompson

Cell and Gene Therapy Catapult

Tim Watts

Oxford BioMedica

Dr Will West

CellCentric

Dr Sam Williams

Modern BioSciences

 

Dr Celia Caulcott

UCL Business

Dr Dan Mahony

Polar Capital

Diana Sternfeld

FieldFisher

David Willetts

The Biotech Growth Trust

David's Bio

 

Steve Bates

Chief Executive Officer

BIA

Since his appointment as Chief Executive of the BioIndustry Association in 2012, Steve has led major BIA campaigns for, amongst other things, improved access to finance, the refilling of the Biomedical Catalyst, anti-microbial resistance and the opportunity the sector presents to generalist long term investors. Steve champions the adaptive pathway approach to the licensing of new drugs, the need for Early Access and is particularly proud of the working relationship the BIA has established with the UK’s leading medical research charities.

A founder member of United Life Sciences, a strategic partnership representing over 1000 life science and healthcare member companies across the UK and internationally, Steve attends the UK’s Ministerial Industry Strategy Group, and sits on The Royal Society's Science, Industry and Translation Committee.

Beyond the UK Steve is a member of EuropaBio’s Board and its National Association Council and is a founder member of the International Confederation of Biotech Associations. An expert and regular commentator on the sector in the media and at industry-leading conferences Steve has worked both in biotech (as Senior Director at Genzyme UK and Ireland) and at the highest levels of UK government (as Special Advisor to John Reid, MP, during his time in Tony Blair’s government) for over 15 years. Steve was awarded the OBE in January 2017.

 

Nick Gardiner

Chief Operating Officer

BIA

Nick is responsible for overseeing the BIA’s operations, ensuring that all activities are professionally delivered to the highest standard. He will be providing an organisation-wide operational perspective to, and support for, activities and projects.

He has specific responsibility for office management/facilities, financial systems/processes and credit control, company secretariat, human resources and IT/telecoms. Nick joined the BIA in October 2014, bringing with him extensive industry and not-for-profit management experience.

Prior to this role he ran the Clinical Laboratory Division of Lab21. This involved providing specialist laboratory services to the healthcare, pharmaceutical and clinical trials markets. He had management responsibility for all operations, income, laboratory and customer services and client liaison across the Group. He also has specific experience of diagnostic testing within the HIV and HCV disease areas. This was gained through building Delphic Diagnostics into a one-stop-shop for clinicians, enabling more effective patient monitoring and subsequent treatment options.

Nick also has extensive management experience within the not-for-profit sector, working for a trade body representing and building the profile of the business communication industry.